Evaluating a Workbook to Promote Autistic Wellbeing (NCT07630376) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluating a Workbook to Promote Autistic Wellbeing
United Kingdom10 participantsStarted 2026-06
Plain-language summary
The goal of this clinical trial is to examine the feasibility and acceptability of a brief guided self-help wellbeing intervention for autistic adults accessing UK secondary mental health services. The study also aims to begin to evaluate whether use of the workbook is associated with any changes in wellbeing. The main questions it aims to answer are:
1. Is it feasible to recruit and retain autistic adults to participate in the study?
2. Do participants find the workbook acceptable and relevant?
3. Are there measurable improvements in wellbeing following workbook use?
4. What changes, if any, do participants recommend for future versions of the intervention?
Participants will:
* Take part in 4-6 sessions of 30-60 minutes using the guided self-help workbook with the support of a trained National Health Service support worker, assistant psychologist, or mental health professional
* Complete wellbeing questionnaires before, during, and after using the workbook
* Complete brief daily wellbeing ratings throughout the study
* Take part in a 1:1 semi-structured interview of up to an hour to discuss their experience of the workbook
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* A pre-existing diagnosis of autism OR on a waiting list for autism assessment OR self-identified as autistic and scoring above cut-off on the autism quotient (AQ-50) screening questionnaire.
* Aged 18 years or over and able to give informed consent to participate.
* Under the care of a community-based mental health team in Kent and Medway Mental Health NHS Trust and not due for discharge during the study period.
* Have already completed assessment processes (including risk assessment) during intake by the clinical team and a management plan is in place.
* The named clinician assesses that the individual is in sufficiently stable condition to participate in the study, and is likely to remain engaged in the intervention.
* Proficiency in reading and writing English.
* If on medication for mental health, the dose is stable (minimum of 3 months) with no planned changes during the study.
Exclusion Criteria:
* Presence of a moderate to severe learning disability that would limit independent engagement with self-help materials.
* Engaged in another psychological therapy or psychologically-informed intervention, or due to begin another during the study.
* Current acute mental health crisis or elevated risk to self/others requiring intensive intervention (assessed via clinical team judgement).
* Insufficient capacity to engage with the study protocol or complete measures (as determined by the care team).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of participants recruited to the study
Timeframe: 6 months following start of recruitment
2
Proportion of participants who complete the guided self-help intervention
Timeframe: Weeks 2-8
3
Proportion of participants who remain in the study
Timeframe: Weeks 0-12
4
Guided self-help intervention acceptability
Timeframe: Weeks 11-12
5
Completion rate of outcome measures
Timeframe: Weeks 0-12
6
Proportion of participants showing reliable improvement on the ReQoL-20 from baseline (weeks 0-1) to post-intervention (weeks 7-8)
Timeframe: Baseline (weeks 0-1) and post-intervention (weeks 7-8)